ASX Health June Winners Actinogen and Optiscan led a sector in good shape - Stockhead
| EPN Stock | 0.02 0.00 0.00% |
Slightly above 56% of Epsilon Healthcare's investor base is looking to short. The analysis of overall sentiment of trading Epsilon Healthcare stock suggests that many investors are alarmed at this time. Epsilon Healthcare's investing sentiment can be driven by a variety of factors including economic data, Epsilon Healthcare's earnings reports, geopolitical events, and overall market trends.
Epsilon |
ASX Health June Winners Actinogen and Optiscan led a sector in good shape Stockhead
Read at news.google.com
 |
Epsilon Healthcare Fundamental Analysis
We analyze Epsilon Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Epsilon Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Epsilon Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Epsilon Healthcare is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Epsilon Healthcare Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Epsilon Healthcare stock to make a market-neutral strategy. Peer analysis of Epsilon Healthcare could also be used in its relative valuation, which is a method of valuing Epsilon Healthcare by comparing valuation metrics with similar companies.
Peers
Epsilon Healthcare Related Equities
| CIA | Champion Iron | 1.62 | ||||
| RIC | Ridley | 1.09 | ||||
| PCI | Perpetual Credit | 0.86 | ||||
| WBCPI | Westpac Banking | 0.00 | ||||
| PEX | Peel Mining | 0.00 | ||||
| TLX | Telix Pharmaceuticals | 1.02 | ||||
| TLM | Talisman Mining | 4.35 |
Additional Tools for Epsilon Stock Analysis
When running Epsilon Healthcare's price analysis, check to measure Epsilon Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epsilon Healthcare is operating at the current time. Most of Epsilon Healthcare's value examination focuses on studying past and present price action to predict the probability of Epsilon Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epsilon Healthcare's price. Additionally, you may evaluate how the addition of Epsilon Healthcare to your portfolios can decrease your overall portfolio volatility.